Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 9, 2014, Pages 643-649

  Xun, Yun hao ^a   Guo, Jian chun ^a   Lou, Guo qiang ^b   Jiang, Yan ming ^b,c   Zhuang, Zhen jie ^b   Zhu, Meng fei ^b,c   Luo, Yan ^b   Ma, Xiao jie ^c   Liu, Jing ^c   Bian, Dong xue ^c   Shi, Jun ping ^b  

^a Xixi Hospital of Hangzhou   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Mortality; Natural history; Non alcoholic fatty liver disease; Non alcoholic fatty liver disease fibrosis score

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHINESE; COHORT ANALYSIS; DEATH; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE FIBROSIS SCORE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; ASIAN CONTINENTAL ANCESTRY GROUP; CAUSE OF DEATH; CHINA; COMPLICATION; EPIDEMIOLOGY; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CAUSE OF DEATH; CHINA; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84911177289     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12260     Document Type: Article

References (27)

1. Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2012; 10: 837-58.
2. Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
3. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis. Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 2011; 43: 617-49.
4. Stepanova M, Rafiq N, Makhlouf H et al. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). Dig. Dis. Sci. 2013; 58: 3017-23.
5. White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin. Gastroenterol. Hepatol. 2012; 10: 1342-59.
6. Pais R, Charlotte F, Fedchuk L et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J. Hepatol. 2013; 59: 550-6.
7. Angulo P. Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance? Hepatology 2010; 51: 373-5.
8. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
9. Rafiq N, Bai C, Fang Y et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin. Gastroenterol. Hepatol. 2009; 7: 234-8.
10. Pagadala MR, McCullough AJ. The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin. Liver Dis. 2012; 16: 487-504.
11. Angulo P, Hui JM, Marchesini G et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007; 45: 846-54.
12. Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2011; 53: 325-35.
13. Wong VW, Wong GL, Chim AM et al. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am. J. Gastroenterol. 2008; 103: 1682-8.
14. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013; 57: 1357-65.
15. Treeprasertsuk S, Bjornsson E, Enders F, Suwanwalaikorn S, Lindor KD. NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients. World J. Gastroenterol. 2013; 19: 1219-29.
16. Angulo P, Bugianesi E, Bjornsson ES et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013; 145: 782-9.
17. Xun YH, Fan JG, Zang GQ et al. Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. J. Dig. Dis. 2012; 13: 588-95.
18. Fan JG, Jia JD, Li YM et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010 [published in Chinese in the Chinese J Hepatol. 2010; 18: 163-6]. J. Dig. Dis. 2011; 12: 38-44.
19. Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J. Gastroenterol. Hepatol. 2013; 28(Suppl. 1): 11-7.
20. Adams LA, Lymp JF, St Sauver J et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005; 129: 113-21.
21. Bhala N, Angulo P, van der Poorten D et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study. Hepatology 2011; 54: 1208-16.
22. Wong VW, Wong GL, Choi PC et al. Disease progression of non-alcoholic fatty liver disease: A prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-74.
23. Farrell GC, Wong VW, Chitturi S. NAFLD in Asia: As common and important as in the West. Nat. Rev. Gastroenterol. Hepatol. 2013; 10: 307-18.
24. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-51.
25. Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008; 57: 1441-7.
26. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.
27. Sterling RK, Lissen E, Clumeck N et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43: 1317-25.